Parker Laboratories, Inc.

UltraDrape^®  UGPIV Barrier and Securement

Downloads

• UltraDrape Application Instructions PM-034-0001D (2023)
• UltraDrape and UltraDrape II Detail Aid MKT-32-0019 (2023)
• UltraDrape and UltraDrape II IFU PM-034-0002D (2023)
• UltraDrape Detail Aid Brochure MKT 34-25-8 Rev 2 (2022 - Sidebar link 4)
• UltraDrape Detail Aid MKT 34-25-8 Rev 2 (2022)
• Instructions for Use PM-034-0002B (2019)
• Application Instructions PM-034-0001B (2019)
• Instructions for Use PM-034-0002A (2018)
• Clinical Product Evaluation of UltraDrape
• A Need for UGPIV Standardization
• UGPIV White Paper
• Cost Effectiveness of UltraDrape for UGPIV
• Get Acrobat

Links

• Request a sample
• Research Finds Significant UGPIV Variation
• Contamination of Point-of-Care Ultrasound Transducers Alarms Key Clinician
• Ultrasound Transducers: Avoiding Gel Contamination and Using Proper Level Disinfection
• Standardized Ultrasound-Guided PIV Insertions Improve Outcomes and Reduce Costs

Features

• Sterile
• Not made with natural rubber latex
• A single dressing provides barrier and securement
• Film layer used during ultrasound guidance is easily discarded, eliminating the need to clean transmission gel from skin

Benefits

• ASAP-approved for facilitating Standard-ANTT® (aseptic, non-touch technique)
• Helps reduce procedure cost when compared with sterile gels and covers
• Helps minimize securement failure
• Minimizes post-IV procedure cleanup time
• Provides a "gel-free" insertion site, decreasing risk of contamination and securement failure
• Cost-effective when compared to other UGPIV protocols
• Manufactured with a film layer which provides an effective barrier against all viruses and bacteria as small as 20nm